EUROPEAN FEDERATION OF BIOTECHNOLOGY: EXBO Members

Prof. Dr. Marco Soria

Department of Experimental & Clinical Medicine 'G. Salvatore'
Magna Graecia University School of Medicine
Via T. Campanella, 115
I-88100 Cantanzaro
Phone +39 - 0961 77 08 80 ; Fax +39 - 0961 77 74 35
E-mail soria@unicz.it

Prof. Dr. Marco Soria
Chairman of the EFB Section on Applied Functional Genomics

Biographical sketch:

2002 - Professor of Biochemistry, University of Cantanzaro
2001 - Senior VP, MediMed Spa, Milano
2000 - 2002 Adjunct Professor of Molecular Biology and Biotechnology, Polytechnic University, Milano
1990 - 2000 Head, Biotechnology Unit, Department of Biological and Technological Research, San Raffaele Institute, Milano
1994 - 1999 Adjunct Professor of Molecular Pathology, School of Medicine, University of Milano
1977 - 1993 Adjunct Professor of Microbiology and Molecular Genetics, School of Pharmacy, University of Milano
1982 - 1990 Head of the Laboratory of Molecular Biology, Farmitalia Carlo Erba, Milano (later expanded to Department of Biotechnological Research)
1977 - 1982 Research Scientist, Department of Genetics, University of Pavia, Italy
1975 - 1976 Project manager, ALZA Corp. Drug Delivery Systems, Milano, Italy
1975 Ph.D. degree, Department of Biochemistry and Molecular Biology, Harward University
1970 - 1975 predoctoral trainee, Harvard University, Cambridge, MA, USA
1969 - 1970 Visiting Fellow of the International Fogarty Center, Laboratory of Chemical Biology, National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, Bethesda, MD, USA
1969 M.D. degree, University of Naples, Italy
1967 - 1968 Visiting Fellow, Department of Chemical Immunology, the Weizmann Institute of Science, Rehovot, Israel

Current research activities:

Gene Expression in vascular cells
Aims:
To study relationships between components of the vascular cell machinery (receptors, adhesion molecules, cytokines, cytoskeleton) and regulation of gene expression in normal vs. pathological situations like cancer and AIDS.
Nonviral gene delivery
Aims:
1. To obtain regulated, multi-subunit gene expression in vitro and in vivo in appropriate districts of the organism.
2. To modify the glycosylation profile of recombinant proteins expressed in non-human cell lines used in biotechnological production, such that it most closely resembles the profile of their human counterparts.

close window